Powell, Nicholas R. http://orcid.org/0000-0003-4572-0733
Liang, Tiebing http://orcid.org/0000-0002-8445-3765
Ipe, Joseph
Cao, Sha http://orcid.org/0000-0002-8645-848X
Skaar, Todd C.
Desta, Zeruesenay
Qian, Hui-Rong
Ebert, Philip J.
Chen, Yu
Thomas, Melissa K.
Chalasani, Naga http://orcid.org/0000-0003-4082-3178
Article History
Received: 20 July 2022
Accepted: 7 March 2023
First Online: 17 March 2023
Competing interests
: Dr. Chalasani has paid consulting agreements with Abbvie, Zydus, Galectin, Madrigal, Foresite, Altimmune, and Boehringer-Ingelheim. He receives research grant support from Exact Sciences, DSM, and Galectin. He has equity ownership in RestUp, LLC, a healthcare placement start-up company. Drs Qian, Ebert, Chen, and Thomas are employees and shareholders of Eli Lilly and Company. Dr. Ipe is an employee of 10 x Genomics and this work was done when he was a faculty member at the Indiana University School of Medicine. Dr. Powell is a shareholder and former employee of Eli Lilly and Company and joined the Indiana University School of Medicine prior to initiating this work. The remaining authors declare no relevant conflicts of interest.